Associations rename fatty liver disease to reduce stigma

Three national liver associations have renamed fatty liver disease as steatotic liver disease to be more “affirmative” and less stigmatising to patients, they announced at the European Association for the Study of the Liver’s (EASL) congress in Vienna.Non-alcoholic fatty liver disease will now be called metabolic dysfunction associated steatotic liver disease (MASLD).And a new category, MetALD, describes those with MASLD who consume greater amounts of alcohol a week (140 g a week for women and 210 g a week for men).The renaming comes after a two year process led by the American Association for Study of Liver Disease and EASL in collaboration with the Asociación Latinoamericana para el Estudio del Hígado. Details of the renaming will be published in the Journal of Hepatology.1Academic professionals from around the world including hepatologists, gastroenterologists, paediatricians, endocrinologists, hepatopathologists, and public health and obesity experts have been involved in the consultations. A total of 236…
Read Original Article: Associations rename fatty liver disease to reduce stigma »